Publications by authors named "Shelah Leader"
Article Synopsis
- The study aimed to estimate cost savings for patients with chronic obstructive pulmonary disease (COPD) who followed the Global Initiative for Chronic Obstructive Lung Disease (GOLD) treatment guidelines using various medication combinations.
- Researchers analyzed data from the Geisinger Health System database, identifying 364 patients (ages 40 and older) based on their first prescription for COPD medications and their adherence to GOLD guidelines, which was determined by pulmonary function tests (PFTs).
- Results showed that adherence to GOLD guidelines resulted in significant healthcare cost savings, with amounts ranging from $3,330 to $10,217, depending on the type of medication regimen used.
Background: School children (5-17 years) function as vectors in influenza epidemics. The objective of this study was to quantify the burden of influenza-like illness (ILI) on US healthy households with school-aged children.
Methods: The Medical Expenditure Panel Survey database of 1996-2002 was queried to compare annual total medical expenses and absenteeism incurred by otherwise healthy households with school-aged children that reported experiencing ILI to similar households that did not experience ILI.
To document the rate and cost of antibiotic prescribing for patients diagnosed only with influenza during US ambulatory care visits. Federal survey data for 1997-2001 were used to estimate outpatient trends for all patients and healthy people age 5-49 years. Cost estimates were based on Medicare payments and Red Book average wholesale prices in 2003.
View Article and Find Full Text PDFObjectives: To provide current estimates of the incidence, associated risk factors, and costs of severe respiratory syncytial virus (RSV) infections among infants in the United States, defined as emergency department (ED) visits, hospitalization, and death.
Study Design: Retrospective analysis of National Hospital Ambulatory Medical Care Survey data 1997 to 2000; National Hospital Discharge Survey data 1997 to 2000; Perinatal Mortality Linked Files 1998 to 1999. The Hospital Cost Utilization Inpatient Sample data 1997 to 2000 were used to estimate hospitalization costs, and the 2001 Medicare fee schedule was used to estimate ED visit costs.
Objective: The objective of this study was to quantify time spent plus out-of-pocket costs associated with confirmed respiratory syncytial virus (RSV) hospitalization of infants not prophylaxed against RSV.
Methods: A prospective survey was carried out at multiple tertiary care hospitals in the United States.
Patients: The patients consisted of a consecutive sample of infants <12 months, born between 33 and 35 weeks of gestation.
Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.
Pediatr Infect Dis J
July 2002
Background: The recent number and rate of infant hospitalizations with a respiratory syncytial virus (RSV)-coded diagnosis have not been published.
Methods: Retrospective data analysis. National Hospital Discharge Survey data for 1997 to 1999 were analyzed for discharges of infants < 1 year old with an RSV-coded diagnosis (ICD-9-CM 466.
Objectives: To describe a method for measuring the direct and indirect costs to families of infants hospitalized with respiratory syncytial virus (RSV).
Methods: After pretesting and revising a questionnaire, a prospective survey was conducted in multiple tertiary-care hospitals with pediatric intensive care units. Eligible patients were infants less than 12 months old who had not received RSV prophylaxis and were hospitalized with a confirmed RSV infection.